{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T03:00:21Z","timestamp":1784948421846,"version":"3.55.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015243","name":"Tsinghua-Berkeley Shenzhen institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.canlet.2020.12.042","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T12:31:19Z","timestamp":1610368279000},"page":"97-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives"],"prefix":"10.1016","volume":"502","author":[{"given":"Vipul","family":"Bhardwaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-2023","authenticated-orcid":false,"given":"Yan Qin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8420-3750","authenticated-orcid":false,"given":"Ming Ming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Lobie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.12.042_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA","volume":"68","author":"Bray","year":"2018","journal-title":"Cancer J. Clin."},{"key":"10.1016\/j.canlet.2020.12.042_bib2","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch. Int. J. Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.12.042_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13048-019-0494-4","article-title":"Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients","volume":"12","author":"Zhang","year":"2019","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib5","first-page":"635","article-title":"Ovarian cancer: diagnosis and treatment, Dtsch","volume":"108","author":"Burges","year":"2011","journal-title":"Arzteblatt Int"},{"key":"10.1016\/j.canlet.2020.12.042_bib6","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1080\/14737140.2017.1398088","article-title":"Optimizing treatment in recurrent epithelial ovarian cancer","volume":"17","author":"Corrado","year":"2017","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.canlet.2020.12.042_bib7","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"B","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.12.042_bib8","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.3390\/ijms14046624","article-title":"Regulation of ovarian cancer stem cells or tumor-initiating cells","volume":"14","author":"Kwon","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2020.12.042_bib9","doi-asserted-by":"crossref","first-page":"44719","DOI":"10.18632\/oncotarget.8089","article-title":"An overview of long non-coding RNAs in ovarian cancers","volume":"7","author":"Meryet-Figui\u00e8re","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ccr.2014.07.009","article-title":"A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer","volume":"26","author":"Hu","year":"2014","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","article-title":"Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer","volume":"77","author":"Zhao","year":"2017","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib12","first-page":"177","article-title":"Transcriptional and post-transcriptional gene regulation by long non-coding RNA","volume":"15","author":"Dykes","year":"2017","journal-title":"Dev. Reprod. Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ijc.30039","article-title":"From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis","volume":"139","author":"Dhamija","year":"2016","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2020.12.042_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1073\/pnas.0706729105","article-title":"Specific expression of long noncoding RNAs in the mouse brain","volume":"105","author":"Mercer","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.canlet.2020.12.042_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000176","article-title":"Differentiating protein-coding and noncoding RNA: challenges and ambiguities","volume":"4","author":"Dinger","year":"2008","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib16","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2217\/epi.15.79","article-title":"Regulatory RNAs and control of epigenetic mechanisms: expectations for cognition and cognitive dysfunction","volume":"8","author":"Butler","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.canlet.2020.12.042_bib17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.tcb.2011.04.001","article-title":"Long noncoding RNAs and human disease","volume":"21","author":"Wapinski","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semcdb.2011.01.001","article-title":"Long noncoding RNAs in cell biology","volume":"22","author":"Clark","year":"2011","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrm3679","article-title":"RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts","volume":"14","author":"Geisler","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cell.2013.06.020","article-title":"lincRNAs: genomics, evolution, and mechanisms","volume":"154","author":"Ulitsky","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib21","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","article-title":"Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs","volume":"129","author":"Rinn","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.cell.2010.09.049","article-title":"The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation","volume":"143","author":"Tian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Canc. Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib24","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.18632\/oncotarget.12537","article-title":"Dysregulation of long non-coding RNA in breast cancer: an overview of mechanism and clinical implication","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib25","doi-asserted-by":"crossref","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-15-0273","article-title":"TANRIC: an interactive open platform to explore the function of lncRNAs in cancer","volume":"75","author":"Li","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080306","article-title":"Comprehensive analysis of long non-coding RNAs in ovarian cancer reveals global patterns and targeted DNA amplification","volume":"8","author":"Akrami","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.12.042_bib27","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/nbt.1914","article-title":"Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression","volume":"29","author":"Prensner","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2020.12.042_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.biopha.2018.03.071","article-title":"Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and\/or inhibiting NF-\u03baB signaling or PI3K\/AKT\/mTOR pathway","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2020.12.042_bib29","first-page":"411","article-title":"Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils","volume":"38","author":"Shang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res. CR."},{"key":"10.1016\/j.canlet.2020.12.042_bib30","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/mc.22919","article-title":"The long non-coding RNA MALAT1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing","volume":"58","author":"Gordon","year":"2019","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canlet.2020.12.042_bib31","first-page":"138","article-title":"Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials","volume":"10","author":"Liu","year":"2013","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib32","first-page":"3803","article-title":"Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib33","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1159\/000485395","article-title":"Long non-coding RNAs: the new horizon of gene regulation in ovarian cancer","volume":"44","author":"Worku","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2020.12.042_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2015.03.005","article-title":"The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis","volume":"333","author":"Qiu","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib35","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3892\/ijo.2015.2943","article-title":"Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion\/metastasis in serous ovarian cancer","volume":"46","author":"Qiu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2020.12.042_bib36","doi-asserted-by":"crossref","first-page":"32478","DOI":"10.18632\/oncotarget.8744","article-title":"The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer","volume":"7","author":"Qiu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib37","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182101","article-title":"LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a\/HMGA2 axis","volume":"39","author":"Miao","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib38","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1038\/onc.2014.236","article-title":"Regulation of tumor cell migration and invasion by the H19\/let-7 axis is antagonized by metformin-induced DNA methylation","volume":"34","author":"Yan","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.12.042_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0301-2115(98)00275-9","article-title":"Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer","volume":"85","author":"Tanos","year":"1999","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib40","first-page":"1340","article-title":"Ginsenoside 20(S)-Rg3 prevents PKM2-targeting miR-324-5p from H19 sponging to antagonize the warburg effect in ovarian cancer cells, cell","volume":"51","author":"Zheng","year":"2018","journal-title":"Physiol. Biochem."},{"key":"10.1016\/j.canlet.2020.12.042_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2019.03.002","article-title":"LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein","volume":"852","author":"Dou","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.canlet.2020.12.042_bib42","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddu502","article-title":"LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b","volume":"24","author":"Gao","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2020.12.042_bib43","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s13277-014-2631-4","article-title":"MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K\/Akt pathway","volume":"36","author":"Dong","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2020.12.042_bib44","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.2147\/OTT.S214689","article-title":"LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p","volume":"12","author":"Sun","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2020.12.042_bib45","first-page":"2644","article-title":"MALAT1 affects ovarian cancer cell behavior and patient survival","volume":"39","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib46","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1158\/1078-0432.CCR-06-2882","article-title":"Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer","volume":"13","author":"Guan","year":"2007","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib47","first-page":"20565","article-title":"Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopha.2018.06.112","article-title":"Long non-coding RNA PVT1 promotes cell proliferation and invasion through regulating miR-133a in ovarian cancer","volume":"106","author":"Yang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2020.12.042_bib49","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.18632\/oncotarget.4541","article-title":"A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib50","first-page":"7200","article-title":"Long non-coding RNA LSINCT5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the CXCL12\/CXCR4 signalling axis","volume":"15","author":"Long","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2020.12.042_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.omtn.2019.05.007","article-title":"lncRNA UCA1 mediates resistance to cisplatin by regulating the miR-143\/FOSL2-signaling pathway in ovarian cancer","volume":"17","author":"Li","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.canlet.2020.12.042_bib52","first-page":"322","article-title":"LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290","volume":"22","author":"Lai","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2020.12.042_bib53","first-page":"145","article-title":"The lncRNA CCAT1 upregulates TGF\u03b2R1 via sponging miR-490-3p to promote TGF\u03b21-induced EMT of ovarian cancer cells","volume":"18","author":"Mu","year":"2018","journal-title":"Canc. Cell Int."},{"key":"10.1016\/j.canlet.2020.12.042_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2147\/OTT.S182657","article-title":"Long noncoding RNA SNHG15 serves as an oncogene and predicts poor prognosis in epithelial ovarian cancer","volume":"12","author":"Qu","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2020.12.042_bib55","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1002\/jcb.29474","article-title":"The lncRNA SNHG15\/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt\/mTOR signaling pathway","volume":"121","author":"Zhang","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2020.12.042_bib56","first-page":"73","article-title":"Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression","volume":"16","author":"Ma","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib57","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.3892\/or.2015.4318","article-title":"Long non-coding RNA growth arrest-specific transcript 5 is involved in ovarian cancer cell apoptosis through the mitochondria-mediated apoptosis pathway","volume":"34","author":"Gao","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib58","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4161\/rna.8.3.14800","article-title":"LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation","volume":"8","author":"Silva","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib59","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/cas.13647","article-title":"Long non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis through regulation of miR-382-3p\/ROCK1 axial","volume":"109","author":"Liu","year":"2018","journal-title":"Canc. Sci."},{"key":"10.1016\/j.canlet.2020.12.042_bib60","first-page":"769","article-title":"Relationship of XIST expression and responses of ovarian cancer to chemotherapy","volume":"1","author":"Huang","year":"2002","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.canlet.2020.12.042_bib61","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1207808","article-title":"Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells","volume":"23","author":"Kawakami","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.12.042_bib62","doi-asserted-by":"crossref","first-page":"34745","DOI":"10.18632\/oncotarget.5784","article-title":"A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer","volume":"6","author":"Richards","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrc1098","article-title":"The pathogenesis of cancer metastasis: the \u201cseed and soil\u201d hypothesis revisited","volume":"3","author":"Fidler","year":"2003","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.12.042_bib64","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajog.2013.04.019","article-title":"The role of the fallopian tube in the origin of ovarian cancer","volume":"209","author":"Erickson","year":"2013","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.canlet.2020.12.042_bib65","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib66","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/labinvest.2017.41","article-title":"The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors","volume":"97","author":"Hardin","year":"2017","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib67","doi-asserted-by":"crossref","first-page":"110685","DOI":"10.18632\/oncotarget.22161","article-title":"LncRNAs and their role in cancer stem cells","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib68","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/0008-5472.CAN-14-3225","article-title":"Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance","volume":"75","author":"Adorno-Cruz","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11071008","article-title":"The role of cancer stem cells and mechanical forces in ovarian cancer metastasis","volume":"11","author":"Bregenzer","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2020.12.042_bib70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1083\/jcb.201202014","article-title":"The evolving concept of cancer and metastasis stem cells","volume":"198","author":"Baccelli","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib71","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s13402-018-0406-4","article-title":"The emerging role of lncRNAs in the regulation of cancer stem cells","volume":"41","author":"Castro-Oropeza","year":"2018","journal-title":"Cell. Oncol. Dordr."},{"key":"10.1016\/j.canlet.2020.12.042_bib72","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.12688\/f1000research.9086.1","article-title":"Neck keloids: evaluation of risk factors and recommendation for keloid staging system","volume":"5","author":"Tirgan","year":"2016","journal-title":"F1000Research"},{"key":"10.1016\/j.canlet.2020.12.042_bib73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1746-1596-8-198","article-title":"The association between chemosensitivity and Pgp, GST-\u03c0 and Topo II expression in gastric cancer","volume":"8","author":"Geng","year":"2013","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib74","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ygyno.2019.12.020","article-title":"The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer","volume":"156","author":"Wambecke","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.12.042_bib75","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1158\/0008-5472.CAN-06-2004","article-title":"Characterization of a germ-line deletion, including the entire INK4\/ARF locus, in a melanoma-neural system tumor family: identification of ANRIL, an antisense noncoding RNA whose expression coclusters with ARF","volume":"67","author":"Pasmant","year":"2007","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12342","article-title":"CCAT2: a novel oncogenic long non-coding RNA in human cancers","volume":"50","author":"Xin","year":"2017","journal-title":"Cell Prolif"},{"key":"10.1016\/j.canlet.2020.12.042_bib77","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2017.01.016","article-title":"Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: a meta-analysis","volume":"466","author":"Fan","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.canlet.2020.12.042_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13000-016-0499-x","article-title":"The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis","volume":"11","author":"Huang","year":"2016","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib79","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1007\/s13277-014-2259-4","article-title":"Clinical significance of the low expression of FER1L4 in gastric cancer patients","volume":"35","author":"Liu","year":"2014","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2020.12.042_bib80","doi-asserted-by":"crossref","first-page":"13445","DOI":"10.1038\/srep13445","article-title":"Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression","volume":"5","author":"Xia","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib81","article-title":"Overexpression of the lncRNA FER1L4 inhibits paclitaxel tolerance of ovarian cancer cells via the regulation of the MAPK signaling pathway","author":"Liu","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.canlet.2020.12.042_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/375034a0","article-title":"Disruption of imprinting caused by deletion of the H19 gene region in mice","volume":"375","author":"Leighton","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.12.042_bib83","doi-asserted-by":"crossref","first-page":"29625","DOI":"10.1074\/jbc.M504033200","article-title":"H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1","volume":"280","author":"Berteaux","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2020.12.042_bib84","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-015-0458-2","article-title":"The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory","volume":"14","author":"Raveh","year":"2015","journal-title":"Mol. Canc."},{"key":"10.1016\/j.canlet.2020.12.042_bib85","first-page":"10082","article-title":"Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer","volume":"8","author":"Zhu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2020.12.042_bib86","first-page":"474","article-title":"Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer","volume":"6","author":"Chen","year":"2000","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib87","first-page":"6442","article-title":"Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2","volume":"62","author":"Cui","year":"2002","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib88","doi-asserted-by":"crossref","first-page":"26093","DOI":"10.1038\/srep26093","article-title":"The essential role of H19 contributing to cisplatin resistance by regulating glutathione metabolism in high-grade serous ovarian cancer","volume":"6","author":"Zheng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib89","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2148-11-102","article-title":"The sequence, structure and evolutionary features of HOTAIR in mammals","volume":"11","author":"He","year":"2011","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib90","first-page":"3","article-title":"The role of long non-coding RNAs in ovarian cancer, Iran","volume":"21","author":"Nikpayam","year":"2017","journal-title":"Biomed. J."},{"key":"10.1016\/j.canlet.2020.12.042_bib91","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2014.03.556","article-title":"Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer","volume":"134","author":"Qiu","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.canlet.2020.12.042_bib92","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yexcr.2015.03.005","article-title":"The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis","volume":"333","author":"Qiu","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib93","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2020.12.042_bib94","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4161\/rna.20481","article-title":"The hallmarks of cancer: a long non-coding RNA point of view","volume":"9","author":"Gutschner","year":"2012","journal-title":"RNA Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib95","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s13277-015-3998-6","article-title":"Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt\/\u03b2-catenin pathway in human ovarian cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2020.12.042_bib96","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1757-2215-7-16","article-title":"Wnt\/\u03b2-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer","volume":"7","author":"Bodnar","year":"2014","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib97","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2017-0274","article-title":"The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7","volume":"399","author":"Liu","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.canlet.2020.12.042_bib98","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3892\/mmr.2015.3562","article-title":"HOTAIR is a potential target for the treatment of cisplatin-resistant ovarian cancer","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib99","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.onc.1209846","article-title":"A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas","volume":"26","author":"Lin","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.12.042_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131699","article-title":"Cell free DNA of tumor origin induces a \u201cmetastatic\u201d expression profile in HT-29 cancer cell line","volume":"10","author":"F\u0171ri","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.canlet.2020.12.042_bib101","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.18632\/oncotarget.6806","article-title":"A MALAT1\/HIF-2\u03b1 feedback loop contributes to arsenite carcinogenesis","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib102","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/s41598-017-00763-y","article-title":"Identification of a six-lncRNA signature associated with recurrence of ovarian cancer","volume":"7","author":"Yang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib103","first-page":"3176","article-title":"LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway","volume":"21","author":"Jin","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2020.12.042_bib104","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.2147\/OTT.S147586","article-title":"LncRNA NEAT1 contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEB1 expression via miR-194","volume":"10","author":"An","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.canlet.2020.12.042_bib105","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1158\/1078-0432.CCR-06-0134","article-title":"Rapid identification of UCA1 as a very sensitive and specific unique marker for human bladder carcinoma","volume":"12","author":"Wang","year":"2006","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib106","first-page":"6357","article-title":"Urinary exosomal expression of long non-coding RNAs as diagnostic marker in bladder cancer","volume":"10","author":"Yazarlou","year":"2018","journal-title":"Canc. Manag. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib107","doi-asserted-by":"crossref","first-page":"3729830","DOI":"10.1155\/2016\/3729830","article-title":"Clinical significance of UCA1 to predict metastasis and poor prognosis of digestive system malignancies: a meta-analysis","volume":"2016","author":"Sun","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.canlet.2020.12.042_bib108","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/IGC.0000000000000828","article-title":"Dysregulated expression of long noncoding RNAs in ovarian cancer","volume":"26","author":"Zhong","year":"2016","journal-title":"Int. J. Gynecol. Canc."},{"key":"10.1016\/j.canlet.2020.12.042_bib109","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.febslet.2008.05.012","article-title":"UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion","volume":"582","author":"Wang","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.canlet.2020.12.042_bib110","doi-asserted-by":"crossref","first-page":"10633","DOI":"10.1007\/s13277-016-4917-1","article-title":"UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis","volume":"37","author":"Yang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.canlet.2020.12.042_bib111","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4149\/neo_2015_051","article-title":"Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2020.12.042_bib112","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2018.05.104","article-title":"UCA1 confers paclitaxel resistance to ovarian cancer through miR-129\/ABCB1 axis","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2020.12.042_bib113","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"PLCO Project team, effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.canlet.2020.12.042_bib114","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.7150\/thno.34692","article-title":"Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression","volume":"9","author":"Chang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.canlet.2020.12.042_bib115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.molcel.2016.01.015","article-title":"Allele-specific reprogramming of cancer metabolism by the long non-coding RNA CCAT2","volume":"61","author":"Redis","year":"2016","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.12.042_bib116","doi-asserted-by":"crossref","first-page":"9085195","DOI":"10.1155\/2016\/9085195","article-title":"Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics","volume":"2016","author":"Shi","year":"2016","journal-title":"Dis. Markers"},{"key":"10.1016\/j.canlet.2020.12.042_bib117","article-title":"Altered long noncoding RNAs and survival outcomes in ovarian cancer","volume":"97","author":"Ning","year":"2018","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.canlet.2020.12.042_bib118","doi-asserted-by":"crossref","first-page":"23927","DOI":"10.18632\/oncotarget.14760","article-title":"Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis","volume":"8","author":"Luo","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13048-016-0258-3","article-title":"Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer","volume":"9","author":"Li","year":"2016","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib120","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3892\/or.2016.5200","article-title":"Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer","volume":"36","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib121","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/1078-0432.CCR-16-1402","article-title":"lncRNAs as novel indicators of patients' prognosis in stage I epithelial ovarian cancer: a retrospective and multicentric study","volume":"23","author":"Martini","year":"2017","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib122","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkh023","article-title":"The microRNA Registry","volume":"32","author":"Griffiths-Jones","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib123","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.biopha.2017.01.037","article-title":"Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer","volume":"88","author":"Li","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2020.12.042_bib124","first-page":"2659","article-title":"Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network","volume":"40","author":"Wang","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib125","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13073-015-0233-4","article-title":"HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer","volume":"7","author":"Teschendorff","year":"2015","journal-title":"Genome Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib126","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12253-019-00614-3","article-title":"MEG3: an oncogenic long non-coding RNA in different cancers","volume":"25","author":"Al-Rugeebah","year":"2019","journal-title":"Pathol. Oncol. Res. POR."},{"key":"10.1016\/j.canlet.2020.12.042_bib127","first-page":"5961","article-title":"SNHG15: a promising cancer-related long noncoding RNA","volume":"11","author":"Tong","year":"2019","journal-title":"Canc. Manag. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib128","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/CBM-182160","article-title":"Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo","volume":"24","author":"Zeng","year":"2019","journal-title":"Canc. Biomarkers"},{"key":"10.1016\/j.canlet.2020.12.042_bib129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.yexcr.2017.07.030","article-title":"Long non-coding RNA CCAT1 promotes metastasis and poor prognosis in epithelial ovarian cancer","volume":"359","author":"Cao","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib130","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3892\/or.2016.5200","article-title":"Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer","volume":"36","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib131","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.18632\/oncotarget.13768","article-title":"High lncRNA H19 expression as prognostic indicator: data mining in female cancers and polling analysis in non-female cancers","volume":"8","author":"Peng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib132","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4143\/crt.2016.263","article-title":"Long non-coding RNA HOXA11 antisense promotes cell proliferation and invasion and predicts patient prognosis in serous ovarian cancer","volume":"49","author":"Yim","year":"2017","journal-title":"Cancer Res. Treat. Off. J. Korean Cancer Assoc."},{"key":"10.1016\/j.canlet.2020.12.042_bib133","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3892\/ol.2016.4800","article-title":"Plasma long non-coding RNA MALAT1 is associated with distant metastasis in patients with epithelial ovarian cancer","volume":"12","author":"Chen","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.canlet.2020.12.042_bib134","first-page":"3373","article-title":"Clinical significance of up-regulated lncRNA NEAT1 in prognosis of ovarian cancer","volume":"20","author":"Chen","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2020.12.042_bib135","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.18632\/oncotarget.13737","article-title":"Long non-coding RNA NEAT1 overexpression is associated with poor prognosis in cancer patients: a systematic review and meta-analysis","volume":"8","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib136","doi-asserted-by":"crossref","first-page":"238","DOI":"10.20892\/j.issn.2095-3941.2017.0174","article-title":"LncRNA PVT1 promotes ovarian cancer progression by silencing miR-214","volume":"15","author":"Chen","year":"2018","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib137","doi-asserted-by":"crossref","first-page":"44442","DOI":"10.18632\/oncotarget.10142","article-title":"Long non-coding RNA UCA1 is a predictive biomarker of cancer","volume":"7","author":"Hong","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib138","doi-asserted-by":"crossref","first-page":"57991","DOI":"10.18632\/oncotarget.11155","article-title":"Prognostic value of long non-coding RNA UCA1 in human solid tumors","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.12.042_bib139","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.molmed.2018.01.001","article-title":"Therapeutic targeting of long non-coding RNAs in cancer","volume":"24","author":"Arun","year":"2018","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib140","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev-pharmtox-010716-104846","article-title":"Pharmacology of antisense drugs","volume":"57","author":"Bennett","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.canlet.2020.12.042_bib141","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1261\/rna.037598.112","article-title":"Noncoding RNA and polycomb recruitment","volume":"19","author":"Brockdorff","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.canlet.2020.12.042_bib142","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.molcel.2013.11.012","article-title":"Interactions between JARID2 and noncoding RNAs regulate PRC2 recruitment to chromatin","volume":"53","author":"Kaneko","year":"2014","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.12.042_bib143","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0050203","article-title":"Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development","volume":"5","author":"Kloosterman","year":"2007","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2020.12.042_bib144","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.12.042_bib145","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nbt.3765","article-title":"The chemical evolution of oligonucleotide therapies of clinical utility","volume":"35","author":"Khvorova","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2020.12.042_bib146","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrc3690","article-title":"Oncogenic protein interfaces: small molecules, big challenges","volume":"14","author":"Nero","year":"2014","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.canlet.2020.12.042_bib147","first-page":"328","article-title":"MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer","volume":"12","author":"Pal","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.canlet.2020.12.042_bib148","first-page":"109711","article-title":"SNHG5 enhances Paclitaxel sensitivity of ovarian cancer cells through sponging miR-23a, Biomed","volume":"123","author":"Lin","year":"2020","journal-title":"Pharma"},{"key":"10.1016\/j.canlet.2020.12.042_bib149","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/s41388-019-0860-0","article-title":"MicroRNA-654-5p suppresses ovarian cancer development impacting on MYC, WNT and AKT pathways","volume":"38","author":"Majem","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2020.12.042_bib150","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cam4.710","article-title":"HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer","volume":"5","author":"Chai","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.canlet.2020.12.042_bib151","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3892\/mmr.2016.5572","article-title":"LncRNA HOTAIR controls the expression of Rab22a by sponging miR-373 in ovarian cancer","volume":"14","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.canlet.2020.12.042_bib152","first-page":"70","article-title":"Functional genomics: screening for lncRNA function","volume":"18","author":"Koch","year":"2017","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.canlet.2020.12.042_bib153","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","article-title":"Genome-scale CRISPR-mediated control of gene repression and activation","volume":"159","author":"Gilbert","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.12.042_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/science.aah7111","article-title":"CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells","volume":"355","author":"Liu","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.canlet.2020.12.042_bib155","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1093\/nar\/gku1198","article-title":"Targeting non-coding RNAs with the CRISPR\/Cas9 system in human cell lines","volume":"43","author":"Ho","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib156","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nbt.3715","article-title":"Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library","volume":"34","author":"Zhu","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.canlet.2020.12.042_bib157","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1021\/acs.bioconjchem.9b00028","article-title":"Systemic delivery of tumor-targeting siRNA nanoparticles against an oncogenic LncRNA facilitates effective triple-negative breast cancer therapy","volume":"30","author":"Vaidya","year":"2019","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.canlet.2020.12.042_bib158","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1208\/s12248-009-9140-1","article-title":"Lipidic systems for in vivo siRNA delivery","volume":"11","author":"Wu","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.canlet.2020.12.042_bib159","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1158\/0008-5472.CAN-05-0530","article-title":"Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery","volume":"65","author":"Landen","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.canlet.2020.12.042_bib160","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13045-020-00944-9","article-title":"Targeting EphA2 in cancer","volume":"13","author":"Xiao","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2020.12.042_bib161","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00404-017-4293-0","article-title":"A phase 1\/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian\/peritoneal cancer","volume":"295","author":"Lavie","year":"2017","journal-title":"Arch. Gynecol. Obstet."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383521000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:53:42Z","timestamp":1759593222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383521000100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":161,"alternative-id":["S0304383521000100"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.042","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.12.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}